Smitherman TA, Tietjen GE, Schuh K, Skljarevski V, et al. Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies. Headache 2020 Oct 16. doi: 10.1111/head.13970.
PMID: 33063862